Darbepoetin vs rHuEPO
All‐cause mortality · patients with the anaemia of end‐stage kidney disease undergoing dialysis
Darbepoetin showed no clear difference in all‐cause mortality compared with rHuEPO (moderate certainty).
1 finding from 1 review
- Frequency of administration of erythropoiesis‐stimulating agents for the anaemia of end‐stage kidney disease in… 2014 · Cochrane Headline outcomes onlyRR 1.29 [0.82, 2.02]5 studies · 1596 participantsModerate